Clinical Trial Update: Caffeic Acid Combining High-dose Dexamethasone in Management of ITP [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update on using caffeic acid in combination with high-dose dexamethasone for immune thrombocytopenia (ITP) completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Immune Thrombocytopenia

Drugs mentioned

• Dexamethasone (high-dose) (dexamethasone)
• caffeic acid

Snippet

Sponsor: Shandong University | Conditions: Immune Thrombocytopenia | Phase 4 | Status: COMPLETED